ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 2.03 USD 3.57%
Market Cap: 196.3m USD
Have any thoughts about
ADC Therapeutics SA?
Write Note

ADC Therapeutics SA
Investor Relations

ADC Therapeutics SA is a clinical-stage biotechnology company. The company is headquartered in Epalinges, Vaud and currently employs 312 full-time employees. The company develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. The company employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The firm has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. The company serves customers in the United States, Switzerland, and the United Kingdom.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Ameet Mallik M.B.A., M.S.
CEO & Director
No Bio Available
Mr. Jose I. Carmona M.B.A.
Chief Financial Officer
No Bio Available
Dr. Mohamed Zaki M.D., Ph.D.
Chief Medical Officer
No Bio Available
Ms. Lisa Michelle Kallebo
Corporate Controller & Chief Accounting Officer
No Bio Available
Dr. Michael Mulkerrin Ph.D.
Chief Technical Operations Officer
No Bio Available
Dr. Patrick van Berkel Ph.D.
Chief Scientific Officer
No Bio Available
Amanda Hamilton
Investor Relations Officer
No Bio Available
Mr. Peter J. Graham Esq.
Secretary & Chief Legal Officer
No Bio Available
Ms. Eugenia Litz
Vice President of Investor Relations & Corporate Communications
No Bio Available
Ms. Kimberly Pope
Senior VP & Chief People Officer
No Bio Available

Contacts

Address
VAUD
Epalinges
Biopole, route de la Corniche 3B
Contacts
+41216530200.0
adctherapeutics.com